Postdoctoral Fellowship – Functional Genomics, Proteomics and Bioinformatics
The Centre for Molecular Medicine Norway (NCMM), www.ncmm.uio.no was established in 2008 as a national partnership institution with the European Molecular Biology Laboratory (www.embl.org) together with similar centre in Sweden and Finland under the Nordic EMBL Partnership with an overall objective of facilitating translation of discoveries in basic medical research into clinical practice. NCMM focuses particularly on disease mechanisms where Norway has clear strengths and will investigate mechanisms of non-communicable diseases such as cancer, cardiovascular and CNS-related diseases, inflammation and immune disorders and stem cells.
The Breast Cancer Research group of Antoni Hurtado is seeking to recruit a postdoctoral research for a three-year period with experience in genomics, proteomics and bioinformatics. The Hurtado’s laboratory studies the mechanism of resistance to treatments in breast and endometrial cancers. The laboratory has established collaboration with Norwegian and international laboratories, which are key for the success of the project. The successful candidate will work with a team of researchers and scientists.
The team is looking for a candidate with experience in functional genomics and proteomics. Experience in computational analyses related with High-throughput sequencing is also needed. The post-doc will be responsible of obtaining and analysing both proteomic and genomic data obtained from tissue culture experiments. Moreover, wide knowledge in breast and endometrial of the molecular mechanism driving these pathologies will be an additional value for this job offer.
Inquiries regarding the post can be directed to Antoni Hurtado (email@example.com).
Inquiries regarding the application can be directed to Nina Modahl (firstname.lastname@example.org)
Please submit your application through the web-based recruitment system linked here:
Job type: Contract
Working hours: Full-time
Working days: Day
Application deadline: 31 August, 2016
Expected Start Date: October 2016